Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice.

PubWeight™: 5.99‹?› | Rank: Top 1%

🔗 View Article (PMID 8104709)

Published in Cell on October 22, 1993

Authors

P Mombaerts1, E Mizoguchi, M J Grusby, L H Glimcher, A K Bhan, S Tonegawa

Author Affiliations

1: Howard Hughes Medical Institute, Department of Biology Massachusetts Institute of Technology Cambridge 02139.

Articles citing this

(truncated to the top 100)

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest (1996) 7.97

Inflammatory bowel disease. Annu Rev Immunol (2010) 7.10

Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med (1995) 6.89

A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med (1996) 6.73

IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest (2008) 6.17

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity (2008) 6.08

Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J (1999) 5.49

Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest (1998) 3.85

Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun (1998) 3.80

Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet (2011) 3.65

Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med (1998) 3.50

Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun (1997) 3.21

Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev (1998) 3.09

Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system. Infect Immun (1999) 3.03

CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J Exp Med (1998) 3.01

T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med (1996) 2.79

T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol (1997) 2.76

BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med (2007) 2.70

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med (1996) 2.68

Increased sensitivity to dextran sodium sulfate colitis in IRE1beta-deficient mice. J Clin Invest (2001) 2.67

Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect Immun (1999) 2.50

Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS One (2009) 2.35

Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev (2002) 2.29

Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med (1997) 2.21

Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells. J Exp Med (1999) 2.11

Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest (1999) 2.09

Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells. Am J Pathol (1996) 2.03

Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J Clin Invest (2003) 2.02

Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice. Cell (1993) 1.99

Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology (1997) 1.99

Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. J Clin Invest (2001) 1.96

CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc Natl Acad Sci U S A (1994) 1.96

T-cell alpha beta + and gamma delta + deficient mice display abnormal but distinct phenotypes toward a natural, widespread infection of the intestinal epithelium. Proc Natl Acad Sci U S A (1996) 1.92

Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease. J Exp Med (1996) 1.91

Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol (2002) 1.79

CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest (2002) 1.73

T helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitis. J Exp Med (2002) 1.69

Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J Exp Med (1999) 1.69

An important regulatory role for CD4+CD8 alpha alpha T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease. Proc Natl Acad Sci U S A (2003) 1.65

Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice. J Exp Med (1996) 1.59

Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice. J Clin Invest (1997) 1.52

Inflammatory bowel disease: review from the aspect of genetics. J Gastroenterol (2009) 1.51

Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice. Am J Pathol (2002) 1.50

Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol (2008) 1.48

A novel urease-negative Helicobacter species associated with colitis and typhlitis in IL-10-deficient mice. Infect Immun (1999) 1.46

Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice upon transfer of CD4(+)CD45RB(hi) T cells. J Exp Med (1999) 1.46

Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis. Dig Dis Sci (2004) 1.44

Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol (2012) 1.44

Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease. J Clin Invest (1997) 1.44

The ACCURE-trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicenter trial (NTR2883) and the ACCURE-UK trial: a randomised external pilot trial (ISRCTN56523019). BMC Surg (2015) 1.42

Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J Exp Med (1998) 1.39

IL-10 is critical for Th2 responses in a murine model of allergic dermatitis. J Clin Invest (2003) 1.36

Layers of mutualism with commensal bacteria protect us from intestinal inflammation. Gut (2006) 1.36

Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Dig Dis Sci (1999) 1.34

Characterization of the mucosal cell-mediated immune response in IL-2 knockout mice before and after the onset of colitis. Immunology (1997) 1.33

A paradoxical reduction in susceptibility to colonic injury upon targeted transgenic ablation of goblet cells. J Clin Invest (1999) 1.31

Products of enteropathogenic Escherichia coli inhibit lymphocyte activation and lymphokine production. Infect Immun (1995) 1.30

T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice. J Exp Med (1996) 1.29

Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. Front Biosci (Landmark Ed) (2010) 1.27

Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensins. Dig Dis Sci (2002) 1.26

Interleukin 10 is a growth factor for a population of regulatory T cells. Gut (1998) 1.26

Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo. PLoS One (2012) 1.26

Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response. Gut (2004) 1.26

Intestinal effector T cells in health and disease. Immunity (2009) 1.24

Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis. Immunity (2012) 1.21

Massive thymic deletion results in systemic autoimmunity through elimination of CD4+ CD25+ T regulatory cells. J Exp Med (2004) 1.20

Lymphocyte proliferation in mice congenitally deficient in T-cell receptor alpha beta + cells. Proc Natl Acad Sci U S A (1994) 1.20

Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease. Am J Pathol (1998) 1.18

SAMP1/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis. Inflamm Bowel Dis (2011) 1.17

Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment. PLoS One (2009) 1.16

PAR2 activation alters colonic paracellular permeability in mice via IFN-gamma-dependent and -independent pathways. J Physiol (2004) 1.15

Thymus leukemia antigen controls intraepithelial lymphocyte function and inflammatory bowel disease. Proc Natl Acad Sci U S A (2008) 1.14

T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice. J Exp Med (1995) 1.14

Characterization of immature thymocyte lines derived from T-cell receptor or recombination activating gene 1 and p53 double mutant mice. Proc Natl Acad Sci U S A (1995) 1.14

Activation of virus-specific memory B cells in the absence of T cell help. J Exp Med (2004) 1.13

Cutting edge: Generation of colitogenic Th17 CD4 T cells is enhanced by IL-17+ γδ T cells. J Immunol (2011) 1.13

Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice. Proc Natl Acad Sci U S A (2002) 1.13

Loss of T cell and B cell quiescence precedes the onset of microbial flora-dependent wasting disease and intestinal inflammation in Gimap5-deficient mice. J Immunol (2010) 1.13

Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease. World J Gastroenterol (2007) 1.12

CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-/-) mice, which can be abrogated by anti-CXCL10 antibody inhibition. J Interferon Cytokine Res (2008) 1.11

Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor alpha chain-deficient mice. J Exp Med (1999) 1.08

Gene expression patterns in experimental colitis in IL-10-deficient mice. Inflamm Bowel Dis (2009) 1.08

Chitinase 3-like-1 expression in colonic epithelial cells as a potentially novel marker for colitis-associated neoplasia. Am J Pathol (2011) 1.06

Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models. Mutat Res (2010) 1.06

Changes in human mucosal gamma delta T cell repertoire and function associated with the disease process in inflammatory bowel disease. Mol Med (1997) 1.04

CD4 T cells and major histocompatibility complex class II expression influence worm expulsion and increased intestinal muscle contraction during Trichinella spiralis infection. Infect Immun (1999) 1.02

Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells. Infect Immun (2007) 1.02

Chronic intestinal inflammation induces stress-response genes in commensal Escherichia coli. Gastroenterology (2011) 1.02

TL and CD8αα: Enigmatic partners in mucosal immunity. Immunol Lett (2010) 1.01

Loss of the proapoptotic protein, Bim, breaks B cell anergy. J Exp Med (2006) 1.01

Dose-dependent activation of lymphocytes in endotoxin-induced airway inflammation. Infect Immun (2000) 0.99

Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease. Blood (2011) 0.99

Microflora reactive IL-10 producing regulatory T cells are present in the colon of IL-2 deficient mice but lack efficacious inhibition of IFN-gamma and TNF-alpha production. Gut (2002) 0.99

Animal models of ulcerative colitis and their application in drug research. Drug Des Devel Ther (2013) 0.99

Role of the enteric microbiota in intestinal homeostasis and inflammation. Free Radic Biol Med (2013) 0.98

Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation. Gut (1997) 0.98

Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies. World J Gastroenterol (1998) 0.98

Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease. J Clin Invest (1996) 0.97

Pathogenesis of autoimmunity in alphabeta T cell-deficient lupus-prone mice. Clin Exp Immunol (1998) 0.97

Tumour necrosis factor in mouse models of chronic intestinal inflammation. Immunology (2002) 0.96

Articles by these authors

Somatic generation of antibody diversity. Nature (1983) 28.06

RAG-1-deficient mice have no mature B and T lymphocytes. Cell (1992) 20.97

A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell (1983) 18.86

A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell (2000) 17.61

Sequences at the somatic recombination sites of immunoglobulin light-chain genes. Nature (1979) 11.83

Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol (1986) 10.92

Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes. Nature (1980) 10.19

B lineage--specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science (1985) 9.73

Plasma cell differentiation requires the transcription factor XBP-1. Nature (2001) 9.72

A complete immunoglobulin gene is created by somatic recombination. Cell (1978) 8.53

Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity (1996) 8.16

Subregion- and cell type-restricted gene knockout in mouse brain. Cell (1996) 8.02

Sequences of mouse immunoglobulin light chain genes before and after somatic changes. Cell (1978) 7.53

Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science (1991) 7.25

The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell (1996) 6.96

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell (1995) 6.88

Sequence of a mouse germ-line gene for a variable region of an immunoglobulin light chain. Proc Natl Acad Sci U S A (1978) 6.80

Ordered rearrangement of immunoglobulin heavy chain variable region segments. EMBO J (1984) 6.67

Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature (1996) 6.23

Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions. Proc Natl Acad Sci U S A (1976) 5.81

BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell (1999) 5.63

Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. Science (1992) 5.46

Organization, structure, and assembly of immunoglobulin heavy chain diversity DNA segments. J Exp Med (1982) 5.37

Domains and the hinge region of an immunoglobulin heavy chain are encoded in separate DNA segments. Nature (1979) 5.35

Evidence for a differential avidity model of T cell selection in the thymus. Cell (1994) 5.24

Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences. Nature (1984) 5.19

The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell (1996) 5.13

Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice. Science (1992) 5.03

TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell (1992) 4.76

Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A (1997) 4.74

Junctional sequences of T cell receptor gamma delta genes: implications for gamma delta T cell lineages and for a novel intermediate of V-(D)-J joining. Cell (1989) 4.65

Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci U S A (1997) 4.63

Developmental regulation of T-cell receptor gene expression. Nature (1985) 4.53

Skeletal and CNS defects in Presenilin-1-deficient mice. Cell (1997) 4.50

The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med (2002) 4.47

Gamma/delta cells. Annu Rev Immunol (1993) 4.35

High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell (1994) 4.34

Identification of D segments of immunoglobulin heavy-chain genes and their rearrangement in T lymphocytes. Nature (1981) 4.26

Identification and nucleotide sequence of a diversity DNA segment (D) of immunoglobulin heavy-chain genes. Nature (1981) 4.19

T cell receptor delta gene mutant mice: independent generation of alpha beta T cells and programmed rearrangements of gamma delta TCR genes. Cell (1993) 4.18

An essential role in liver development for transcription factor XBP-1. Genes Dev (2000) 4.17

The transcription factor NF-ATc is essential for cardiac valve formation. Nature (1998) 4.14

Cell-type-specific contacts to immunoglobulin enhancers in nuclei. Nature (1985) 3.94

Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science (1997) 3.92

Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest (1998) 3.85

Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system. J Exp Med (1989) 3.70

Distribution of T cell subsets in human lymph nodes. J Exp Med (1981) 3.64

The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity (1999) 3.61

Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell (2001) 3.55

Homing of a gamma delta thymocyte subset with homogeneous T-cell receptors to mucosal epithelia. Nature (1990) 3.55

Structure, organization, and somatic rearrangement of T cell gamma genes. Cell (1985) 3.49

Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. J Immunol (1998) 3.48

Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen. Nature (1993) 3.47

A third rearranged and expressed gene in a clone of cytotoxic T lymphocytes. Nature (1984) 3.46

Location of T cell and major histocompatibility complex antigens in the human thymus. J Exp Med (1980) 3.41

Transcription of mouse kappa chain genes: implications for allelic exclusion. Proc Natl Acad Sci U S A (1980) 3.38

Activation of the c-myc gene by translocation: a model for translational control. Proc Natl Acad Sci U S A (1983) 3.36

Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice. Cell (1994) 3.35

Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines. J Immunol (1984) 3.26

Cloning of an immunoglobulin variable region gene from mouse embryo. Proc Natl Acad Sci U S A (1977) 3.21

Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. J Immunol (1999) 3.21

Cell type-specific enhancer element associated with a mouse MHC gene, E beta. Nature (1984) 3.16

Complete primary structures of the E beta chain and gene of the mouse major histocompatibility complex. Proc Natl Acad Sci U S A (1983) 3.09

Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity (1996) 3.05

Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells. J Exp Med (1982) 3.01

Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma. Science (1997) 2.98

Variable and constant parts of the immunoglobulin light chain gene of a mouse myeloma cell are 1250 nontranslated bases apart. Proc Natl Acad Sci U S A (1977) 2.93

Activation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy-chain locus. Nature (1984) 2.93

Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity (1998) 2.92

Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol (1983) 2.90

Diversity of murine gamma genes and expression in fetal and adult T lymphocytes. Nature (1986) 2.89

Intestinal intraepithelial lymphocytes are a distinct set of gamma delta T cells. Nature (1988) 2.89

The role of DNA rearrangement and alternative RNA processing in the expression of immunoglobulin delta genes. Cell (1981) 2.85

Intraepithelial lymphocytes modulate Ia expression by intestinal epithelial cells. J Immunol (1984) 2.84

A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter. Science (1990) 2.83

Exon shuffling generates an immunoglobulin heavy chain gene. Proc Natl Acad Sci U S A (1980) 2.80

Monoclonal antibodies specific to native murine T-cell receptor gamma delta: analysis of gamma delta T cells during thymic ontogeny and in peripheral lymphoid organs. Proc Natl Acad Sci U S A (1989) 2.79

Somatic changes in the content and context of immunoglobulin genes. Cold Spring Harb Symp Quant Biol (1977) 2.73

BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. J Immunol (1985) 2.66

Impaired hippocampal representation of space in CA1-specific NMDAR1 knockout mice. Cell (1996) 2.62

DNA clones containing mouse immunoglobulin kappa chain genes isolated by in vitro packaging into phage lambda coats. Proc Natl Acad Sci U S A (1978) 2.60

CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science (1999) 2.60

Cortex-restricted disruption of NMDAR1 impairs neuronal patterns in the barrel cortex. Nature (2000) 2.60

Monoallelic expression of the interleukin-2 locus. Science (1998) 2.58

Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol (1999) 2.58

c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J Exp Med (1998) 2.58

Limited diversity of the rearranged T-cell gamma gene. Nature (1985) 2.58

Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc Natl Acad Sci U S A (1983) 2.57

Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature (1997) 2.57

Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature (1992) 2.55

Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J Exp Med (1997) 2.51